Solasia Pharma K.K. (4597.T)
JPY 34.0
(6.25%)
JPY 34.0
(6.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.55 Billion JPY | -18.63% |
| 2022 | 3.13 Billion JPY | -0.32% |
| 2021 | 3.14 Billion JPY | -45.56% |
| 2020 | 5.77 Billion JPY | -27.32% |
| 2019 | 7.94 Billion JPY | 2.82% |
| 2018 | 7.72 Billion JPY | 16.12% |
| 2017 | 6.65 Billion JPY | 79.62% |
| 2016 | 3.7 Billion JPY | -10.06% |
| 2015 | 4.11 Billion JPY | 119.27% |
| 2014 | 1.87 Billion JPY | 12.57% |
| 2013 | 1.66 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.29 Billion JPY | -15.1% |
| 2024 Q1 | 2.7 Billion JPY | 6.2% |
| 2023 Q4 | 2.55 Billion JPY | 11.94% |
| 2023 FY | 2.55 Billion JPY | -18.63% |
| 2023 Q1 | 2.98 Billion JPY | -4.63% |
| 2023 Q2 | 2.67 Billion JPY | -10.4% |
| 2023 Q3 | 2.27 Billion JPY | -14.94% |
| 2022 Q1 | 3.09 Billion JPY | -1.46% |
| 2022 Q4 | 3.13 Billion JPY | -26.76% |
| 2022 Q3 | 4.27 Billion JPY | 39.38% |
| 2022 Q2 | 3.07 Billion JPY | -0.9% |
| 2022 FY | 3.13 Billion JPY | -0.32% |
| 2021 Q2 | 4.47 Billion JPY | -11.61% |
| 2021 Q4 | 3.14 Billion JPY | -15.32% |
| 2021 Q3 | 3.71 Billion JPY | -17.05% |
| 2021 FY | 3.14 Billion JPY | -45.56% |
| 2021 Q1 | 5.06 Billion JPY | -12.31% |
| 2020 FY | 5.77 Billion JPY | -27.32% |
| 2020 Q4 | 5.77 Billion JPY | -27.13% |
| 2020 Q3 | 7.92 Billion JPY | 29.28% |
| 2020 Q2 | 6.13 Billion JPY | -14.1% |
| 2020 Q1 | 7.13 Billion JPY | -10.19% |
| 2019 Q4 | 7.94 Billion JPY | 30.82% |
| 2019 FY | 7.94 Billion JPY | 2.82% |
| 2019 Q1 | 7.01 Billion JPY | -9.24% |
| 2019 Q3 | 6.07 Billion JPY | -9.19% |
| 2019 Q2 | 6.68 Billion JPY | -4.63% |
| 2018 Q3 | 8.23 Billion JPY | 45.05% |
| 2018 Q2 | 5.67 Billion JPY | -7.42% |
| 2018 Q1 | 6.13 Billion JPY | -7.88% |
| 2018 FY | 7.72 Billion JPY | 16.12% |
| 2018 Q4 | 7.72 Billion JPY | -6.13% |
| 2017 Q3 | 6.99 Billion JPY | 1.35% |
| 2017 Q2 | 6.9 Billion JPY | 2.69% |
| 2017 Q1 | 6.72 Billion JPY | 81.49% |
| 2017 Q4 | 6.65 Billion JPY | -4.9% |
| 2017 FY | 6.65 Billion JPY | 79.62% |
| 2016 Q4 | 3.7 Billion JPY | 2.29% |
| 2016 Q3 | 3.62 Billion JPY | 0.0% |
| 2016 FY | 3.7 Billion JPY | -10.06% |
| 2015 FY | 4.11 Billion JPY | 119.27% |
| 2015 Q4 | 4.11 Billion JPY | 0.0% |
| 2014 FY | 1.87 Billion JPY | 12.57% |
| 2013 FY | 1.66 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | 93.028% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.983% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 99.719% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 99.82% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | 83.464% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 99.032% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 98.514% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 99.817% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | 85.16% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 99.224% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 98.394% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | 96.665% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | 94.853% |
| Tsumura & Co. | 428.25 Billion JPY | 99.405% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 99.023% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | 98.089% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 99.408% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | 97.012% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | 98.306% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | 98.565% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | 83.052% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | 96.718% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | 83.39% |
| MedRx Co., Ltd | 2.05 Billion JPY | -24.269% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | 86.542% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -25.868% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | 97.267% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 99.333% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | 39.499% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 99.67% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | 92.032% |